We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

MedImaging

Download Mobile App
Recent News Radiography MRI Ultrasound Nuclear Medicine General/Advanced Imaging Imaging IT Industry News

Light Scattering Spectroscopy Identifies Malignant Cysts

By MedImaging International staff writers
Posted on 30 Mar 2017
Print article
Image: A novel spectroscopy probe can identify malignancy in pancreatic cysts (Photo courtesy of BIDMC).
Image: A novel spectroscopy probe can identify malignancy in pancreatic cysts (Photo courtesy of BIDMC).
A new light scattering spectroscopy (LSS) device can distinguish between harmless pancreatic cysts and those with malignant potential with high accuracy, according to a new study.

Developed by researchers at Beth Israel Deaconess Medical Center, the new tool, half a millimeter in diameter, detects structural changes in cancerous or pre-cancerous cells by using a spatial gating fiberoptic probe inserted into a fine-needle aspiration (FNA) needle. The miniature fiberoptic probe measures optical spectra from the internal cyst surface to predict malignant potential, before collecting cystic fluid as part of routine diagnostic endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) procedures.

To test the accuracy of the LSS system, the researchers collected and analyzed the reflected light from 13 cysts; they then compared their findings with the results from pre-operative imaging, FNA biopsies, and post-operative tissues analysis. In all cases, the LSS diagnosis agreed with the post-operative analysis. In a second experiment, the LSS tool was tested in 14 patients with pancreatic cysts who were undergoing standard FNA biopsy. Out of nine patients whose cysts had been definitely diagnosed as either cancerous or benign, all were correctly identified by LSS. The study was published on March 13, 2017, in the Nature Biomedical Engineering.

“About one-fifth of pancreatic cancers develop from cysts, but not all lesions are cancerous,” said senior author Lev Perelman, PhD, director of the BIDMC center for advanced biomedical imaging and photonics. “Considering the high risk of pancreatic surgeries and the even higher mortality from untreated pancreatic cancers, there's an obvious need for new diagnostic methods to accurately identify the pancreatic cysts that need surgical intervention, and those that do not.”

Pancreatic cysts are fluid-filled growths that develop in the pancreas. Sometimes pancreatic cysts grow as a result of pancreatitis, an inflammation in the pancreas; but most develop for no apparent reason and are discovered by chance during a computerized tomography (CT) or magnetic resonance imaging (MRI) scan done for another purpose. Most pancreatic cysts are benign, but some have the potential to develop into pancreatic cancer.

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Ultrasound System
Voluson Signature 18
New
CT Phantom
CIRS Model 610 AAPM CT Performance Phantom
New
Compact C-Arm
Arcovis DRF-C S21

Print article

Channels

Ultrasound

view channel
Image: The portable ultrasound system uses AI to speed up triage for patients with suspected injuries (Photo courtesy of 123RF)

Portable Ultrasound Tool Uses AI to Detect Arm Fractures More Quickly

Suspected injuries to the upper limbs are a major reason for visits to hospital emergency departments. Currently, wait times for an X-ray and subsequent doctor consultation can vary widely, typically ranging... Read more

Nuclear Medicine

view channel
Image: Researchers have identified a new imaging biomarker for tumor responses to ICB therapy (Photo courtesy of 123RF)

New PET Biomarker Predicts Success of Immune Checkpoint Blockade Therapy

Immunotherapies, such as immune checkpoint blockade (ICB), have shown promising clinical results in treating melanoma, non-small cell lung cancer, and other tumor types. However, the effectiveness of these... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more